Gene · 8454
Papers4,328
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 4,328
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TRIM2 inhibits apoptosis by ubiquitinating BNIP3 to protect the intestine against ischemia-reperfusion injury in mice. | Commun Biol | 2025 | 40883557 | PubTator, text mining | PubMed |
| Discovery of an allosteric 14-3-3 inhibitor for suppressing NRF2-driven cancer via phenotypic screening and chemoproteomic-based target deconvolution. | Chem Sci | 2025 | 40880779 | PubTator, text mining | PubMed |
| Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers. | Mol Cancer | 2025 | 40847302 | PubTator, text mining | PubMed |
| Cul5Wsb2 uses BCL2 proteins as co-receptors to target Bim for degradation. | bioRxiv | 2025 | 40832228 | PubTator, text mining | PubMed |
| Regulatory role of E3 ubiquitin ligases in multiple myeloma: from molecular mechanisms to therapeutic strategies. | Front Cell Dev Biol | 2025 | 40809696 | PubTator, text mining | PubMed |
| Mechanistic insights into the role of RNA demethylase ALKBH5 in malignant tumor therapy. | J Transl Med | 2025 | 40804394 | PubTator, text mining | PubMed |
| Nucleus-translocated glucokinase functions as a protein kinase to phosphorylate TAZ and promote tumour growth. | Nat Commun | 2025 | 40759645 | PubTator, text mining | PubMed |
| FOXP2 suppresses gastric cancer progression by transcriptionally repressing FBXW2 via WASL degradation. | Cell Death Discov | 2025 | 40721413 | PubTator, text mining | PubMed |
| A network analysis of gene co-expression in post-mortem brain tissues identifying novel genes and biological pathways underlying major depression. | Front Psychiatry | 2025 | 40717780 | PubTator, text mining | PubMed |
| N4BP1 is a nucleocytoplasmic shuttling protein and recognizes aggregates of the ubiquitin-like protein NEDD8 to protect cells under heat shock. | J Biol Chem | 2025 | 40701250 | PubTator, text mining | PubMed |
| A Molecular Recruitment Colocalization Platform for Visualizing Multi-Protein Interactions and Engineering Biomolecular Condensates in Living Cells. | Adv Sci (Weinh) | 2025 | 40692378 | PubTator, text mining | PubMed |
| βTrCP facilitates MRN complex localization on chromatin to enhance DNA repair. | Commun Biol | 2025 | 40646298 | PubTator, text mining | PubMed |
| Design and Semisynthesis of Ubiquitin Extension Probes for Structural Analysis of Cullin1-Mediated Substrate Polyubiquitination. | J Am Chem Soc | 2025 | 40561458 | PubTator, text mining | PubMed |
Cullin-associated and neddylation-dissociated protein 1 (CAND1) promotes cardiomyocyte proliferation and heart regeneration by enhancing the ubiquitinated degradation of Mps one binder kinase activator 1b (Mob1b). | Cell Death Differ | 2025 | 40555744 | PubTator, text mining | PubMed |
| Analysis of cullin family genes in rectal adenocarcinoma: expression, prognostic significance, and therapeutic implications. | Am J Transl Res | 2025 | 40535676 | PubTator, text mining | PubMed |
| F-box proteins at the crossroads of ubiquitination and tumor immunity: regulatory networks and immunotherapy strategies. | Front Immunol | 2025 | 40534867 | PubTator, text mining | PubMed |
| Fbxo16 mediates degradation of NF-κB p65 subunit and inhibits inflammatory response in dendritic cells. | Front Immunol | 2025 | 40529355 | PubTator, text mining | PubMed |
| Prognostic analysis of bladder cancer with neddylation-related genes. | Hereditas | 2025 | 40524221 | PubTator, text mining | PubMed |
| Molecular hybridization strategy - discovery of 2,3-diarylpyrazine derivatives as potent Skp2 inhibitors with improved anti-tumor activity and enhanced cisplatin sensitivity. | Eur J Med Chem | 2025 | 40460720 | PubTator, text mining | PubMed |
| SDCBP/Syntenin-1 stabilizes BACH1 by disassembling the SCFFBXO22-BACH1 complex in triple-negative breast cancer. | EMBO J | 2025 | 40263598 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8454/papers?page=5